Latest Press Releases

Q BioMed Adds Boston University's Dr. Helen Tager-Flusberg to Advisory Committee

LogoQ BioMed Inc., a biotechnology acceleration company, announced today that Dr. Helen Tager-Flusberg from Boston University has joined its advisory committee for QBM-001, which is being tested for pediatric developmental nonverbal disorder in toddlers within the autism spectrum disorders.

New Podcast Episode: How Digital Marketing Helps Small Businesses

LogoDigital marketing is essential for small business to compete with big business. It levels the playing field.